Breakthrough CAR-T Cancer Treatments Are Boosting Patients’ Quality of Life
WEDNESDAY, April 5, 2023 (HealthDay News) — A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.The treatment, called chimeric antigen receptor (CAR) T-cell therapy, is used t…
Learn MoreOutcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
MONDAY, Feb. 6, 2023 (HealthDay News) — Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in the morning, according to a st…
Learn MoreFDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
MONDAY, Jan. 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.The ap…
Learn MoreDelay in Time to Antibiotics Permissible for Inpatient Neutropenic Fever
MONDAY, Jan. 9, 2023 (HealthDay News) — For patients with hematologic malignancy who develop inpatient neutropenic fever, delays in time to antibiotics do not significantly affect overall survival at 180 days, according to a study published in the Ja…
Learn MoreJane Fonda anuncia que su linfoma está en remisión
VIERNES, 16 de diciembre de 2022 (HealthDay News) — La actriz y ganadora de dos premios Oscar Jane Fonda anunció el jueves que su linfoma no Hodgkin está en remisión.Fonda, que tiene 84 años, afirmó en una publicación en su blog que puede dejar los t…
Learn MoreASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B-Cell Lymphoma
MONDAY, Dec. 19, 2022 (HealthDay News) — The bispecific antibody that recruits T cells to tumor cells, glofitamab, is effective for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to a study published online Dec….
Learn MoreJane Fonda Says Her Lymphoma Is in Remission
FRIDAY, Dec. 16, 2022 (HealthDay News) – Actress and two-time Academy Award winner Jane Fonda announced Thursday that her non-Hodgkin lymphoma is in remission.Fonda, 84, said in a blog post that she can quit chemotherapy treatments, calling it the “BE…
Learn MoreUnos estudios muestran que la raza y los ingresos pueden determinar los resultados en el cáncer de sangre
LUNES, 12 de diciembre de 2022 (HealthDay News) — Si alguien desarrolla un cáncer de la sangre o un coágulo sanguíneo potencialmente letal, es probable que le vaya mejor si es blanco y rico, muestran tres estudios recientes.El impacto continuo de la …
Learn MoreRace, Income Can Determine Blood Cancer Outcomes, Studies Show
MONDAY, Dec. 12, 2022 (HealthDay News) — If someone is stricken with a blood cancer or life-threatening clot, they’ll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patient race and income to medical …
Learn MoreShe Thought Cancer Had Won — Until This Experimental Therapy
FRIDAY, Nov. 11, 2022 (HealthDay News) — The breast cancer of author and poet Stephanie Gangi has receded and advanced in wearying waves for two decades now.First diagnosed and treated in 1999, Gangi’s cancer spread to the bone of her sternum in 2014…
Learn More